text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3606200/2021

text: clinical

text: Baseline surveillance


status: PUBLIC

text: SARS-CoV-2: clinical or host-associated

tag: attribute

characteristic: BioSampleModel

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: pda|emily.smith@theiagen.com

characteristic: INSDC center alias

text: pda|emily.smith@theiagen.com

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: NCBI

characteristic: broker name

text: CDPH VBL

text: USA: California

text: Homo sapiens

characteristic: host

text: SARS-CoV-2/Human/USA/CA-CDPH-N3606602/2021

characteristic: isolate

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

characteristic: organism

text: Baseline surveillance

characteristic: title


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3608168/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3608231/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3608386/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3608902/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3609054/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3614626/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3615058/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3615441/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3618171/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3618207/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3618296/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3618630/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3620375/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3620837/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3622430/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3626701/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3626783/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3634249/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3634265/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3634276/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3634407/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3634593/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3635127/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3635282/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3635683/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3635704/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3635828/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3636225/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3636238/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3640412/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3641182/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3643137/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3643669/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3643695/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3644387/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3646539/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3648532/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3649291/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3649624/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3651112/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3651376/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3651439/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3652412/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3653440/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3653458/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3653884/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3655531/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3658724/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3659392/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3660017/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3660090/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3660455/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3666097/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3667113/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3668884/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3668886/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3672473/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3678630/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3681068/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3681903/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3681909/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3682781/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3684570/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3698311/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3699264/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3701228/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3708025/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3709325/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3709440/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3711659/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3711790/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3713133/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3714786/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3718336/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3730495/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3731519/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3734428/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3735509/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3737208/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3737290/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3741095/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3742911/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3744113/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3744741/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3745358/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3746976/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3748032/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3748607/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3748620/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3751966/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3756187/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3756756/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3760133/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3760540/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3763041/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3763401/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3764829/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3765051/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3770649/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3775201/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3777709/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3782861/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3789934/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3789955/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3792819/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3804876/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3820160/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3827328/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3829036/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3829050/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3829072/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3830281/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3830852/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3834046/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3834151/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3835230/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3836200/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3840135/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3843869/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3845166/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3845216/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3848844/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3849791/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3859517/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3863482/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3868856/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3872327/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3876065/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3877051/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3877090/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3877092/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3877119/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3877157/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3877172/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3877185/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3877252/2021

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3879549/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3880166/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3884706/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3884707/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3884820/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3885458/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3885903/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-N3889746/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-NA0043862846/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-NA0043929132/2021

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-0CSBWTE0YWMX9/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-2PAAWK1AHXX5R/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3NMRNMHGA2YXR/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-5E9YNEKYK04K0/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-9HEKXDRHFTB7B/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-A6EB3ZGGDGWDH/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-AFP1CCFWMZREG/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-AKMD39GYTHECB/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-B0PZNRBDFM6D9/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-CB741HDBV0THT/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-CNNAN2Z7BVVTR/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-DAPM18X7M03ZA/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-DHYSZDHNFK6HH/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-DM807VG5SP7NW/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-DRENWRNPHFGW7/2022

text: clinical

text: Baseline surveillance


CA-CDPH-EZADGSPVXYGAX

text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: CA-CDPH-EZADGSPVXYGAX

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-EZADGSPVXYGAX/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: Airport Antigen COVIDNet Project

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FRTPM5WWXMRVR/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24952375/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24952387/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24952420/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24952463/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24952488/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24952895/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24952932/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24952942/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24953311/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24954358/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24954402/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24954513/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24954529/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24955089/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24955150/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24955430/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24955496/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS24955851/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25172120/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25172200/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25172716/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25172991/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25173476/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25174278/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25174753/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25436284/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25436612/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25438137/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25438169/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25438182/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25438200/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25438205/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25438313/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25439278/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25439599/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25440006/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25440642/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25454558/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25532539/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25532601/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25532721/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25532814/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25533412/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25533419/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25533420/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25533661/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25533682/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25533693/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25533776/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25534565/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25534592/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25535040/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25535167/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25535183/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25535301/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS25536168/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27224177/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27225284/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27225444/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27225465/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27245383/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27271718/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27271754/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27277041/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27277301/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27277317/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27390701/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27391018/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27395126/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27395174/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27410893/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27412917/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27413382/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27413386/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27413419/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27413569/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27413582/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27413598/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27413688/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS27630055/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS46913253/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS46914675/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS46915097/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS46916724/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS46917151/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47043668/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47043849/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47046066/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47051411/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47125219/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47148825/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47148921/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47149420/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47149536/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47149925/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47150963/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47151131/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47151198/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47151509/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47151879/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47152639/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47152671/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47152957/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47166288/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47282707/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47283050/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47283171/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47283373/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47283592/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47283616/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47283706/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47283819/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47284076/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47285649/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47285984/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47287188/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47289008/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47289154/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47289380/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47290937/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47291008/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47291814/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47291824/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47292309/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47292447/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47292797/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47293983/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47294013/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47294352/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47294862/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47295560/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47296953/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47297022/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47447936/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47447943/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47465178/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47466053/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47466590/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47466599/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47466613/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47469389/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47469609/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47562109/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47562297/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47562704/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47563898/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47564209/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47564970/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47564985/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47565210/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47571974/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47575485/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47646254/2022

text: clinical

text: Targeted sequencing


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: UC Davis Genome Center

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-FS47646448/2022

text: clinical

text: Targeted sequencing